← Leaderboards

Ann Marshak-Rothstein

Schepens Eye Research Institute

Google Scholar ↗PubMed ↗ORCID ↗

$30,359,235

Attributed

$35,122,787

Total exposure

22

Grants

14

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$48,557,583 · 23

By mechanism

P01$22,107,576 · 7

R01$17,357,382 · 8

T32$4,996,963 · 2

R37$2,474,645 · 1

R21$1,469,538 · 4

U19$151,479 · 1

Top collaborators

Katherine A Fitzgerald18 shared
Meredith Gregory-Ksander5 shared

Others in their field

Top investigators on “Cells”

Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
Barton F Haynes · Duke University$457,457,619
David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
Dennis R. Burton · Scripps Research Institute$278,781,854
Mary M Horowitz · Medical College Of Wisconsin$237,383,608

Research focus

CellsInsightLigandsReceptorB-LymphocytesInflammationProductionIn VivoPathway InteractionsResponseAutoimmune DiseasesIn VitroAutoantibodiesMutationChronicAutoantigensSystemic Lupus ErythematosusTlr7 GeneInflammatoryPathogenesisInterferonsPhenotypeSystemic Autoimmune DiseasePlay

Grant awards (100)

Mechanisms of STING-driven autoinflammation$837,240

R01 · FY2025 · HL

Fas Ligand Cleavage regulates ocular homeostasis and glaucoma$588,524

R01 · FY2025 · EY

The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation$494,929

R37 · FY2025 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$249,522

T32 · FY2025 · AI

Mechanisms of STING-driven autoinflammation$820,495

R01 · FY2024 · HL

Fas Ligand Cleavage regulates ocular homeostasis and glaucoma$600,249

R01 · FY2024 · EY

The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation$494,929

R37 · FY2024 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$242,928

T32 · FY2024 · AI

Radioresistant Innate Immunity in SAVI Tissue-Specific Autoinflammation$209,375

R21 · FY2024 · AI · contact PI

Mechanisms of STING-driven autoinflammation$837,240

R01 · FY2023 · HL

Fas Ligand Cleavage regulates ocular homeostasis and glaucoma$600,249

R01 · FY2023 · EY

The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation$494,929

R37 · FY2023 · AI · contact PI

Radioresistant Innate Immunity in SAVI Tissue-Specific Autoinflammation$251,250

R21 · FY2023 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$243,395

T32 · FY2023 · AI

Fas Ligand Cleavage regulates ocular homeostasis and glaucoma$43,575

R01 · FY2023 · EY

Fas Ligand Cleavage regulates ocular homeostasis and glaucoma$619,633

R01 · FY2022 · EY

The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation$494,929

R37 · FY2022 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$146,885

T32 · FY2022 · AI

Regulation of Lupus by Cytosolic DNA Sensors$535,551

R01 · FY2021 · AI · contact PI

The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation$494,929

R37 · FY2021 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$139,837

T32 · FY2021 · AI

Regulation of Lupus by Cytosolic DNA Sensors$535,551

R01 · FY2020 · AI · contact PI

Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus$209,375

R21 · FY2020 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$138,139

T32 · FY2020 · AI

Regulation of Lupus by Cytosolic DNA Sensors$535,551

R01 · FY2019 · AI · contact PI

Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement$513,647

R01 · FY2019 · AR · contact PI

Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus$251,250

R21 · FY2019 · AI · contact PI

Innate Immune activation of Cutaneous Lupus$209,375

R21 · FY2019 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$141,469

T32 · FY2019 · AI

Regulation of Lupus by Cytosolic DNA Sensors$535,551

R01 · FY2018 · AI · contact PI

Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement$513,647

R01 · FY2018 · AR · contact PI

Innate Immune activation of Cutaneous Lupus$251,250

R21 · FY2018 · AI · contact PI

Training in the Molecular Basis of Autoimmunity and Autoinflammation$139,344

T32 · FY2018 · AI

Regulation of Lupus by Cytosolic DNA Sensors$535,551

R01 · FY2017 · AI · contact PI

Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement$513,647

R01 · FY2017 · AR · contact PI

Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement$513,647

R01 · FY2016 · AR · contact PI

Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement$547,397

R01 · FY2015 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,310,545

P01 · FY2013 · AR · contact PI

CO-FUNDING-NIAID$1,303,359

P01 · FY2013 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$7,183

P01 · FY2013 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,393,290

P01 · FY2012 · AR · contact PI

CO-FUNDING-NIAID$1,385,407

P01 · FY2012 · AR · contact PI

Immunological Mechanisms in Systemic Autoimmune Disease$343,950

R01 · FY2012 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$7,878

P01 · FY2012 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,407,018

P01 · FY2011 · AR · contact PI

CO-FUNDING-NIAID$1,399,105

P01 · FY2011 · AR · contact PI

Immunological Mechanisms in Systemic Autoimmune Disease$343,950

R01 · FY2011 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$1,495

P01 · FY2011 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,454,672

P01 · FY2010 · AR · contact PI

CO-FUNDING-NIAID$1,446,415

P01 · FY2010 · AR · contact PI

Immunological Mechanisms in Systemic Autoimmune Disease$358,281

R01 · FY2010 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$306,840

R01 · FY2010 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$3,332

P01 · FY2010 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,241,065

P01 · FY2009 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$598,731

P01 · FY2009 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$578,796

P01 · FY2009 · AR · contact PI

Immunological Mechanisms in Systemic Autoimmune Disease$357,500

R01 · FY2009 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$276,348

P01 · FY2009 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$219,984

R01 · FY2009 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$86,187

R01 · FY2009 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,027,583

P01 · FY2008 · AR · contact PI

Immunological Mechanisms in Systemic Autoimmune Disease$357,500

R01 · FY2008 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$306,171

R01 · FY2008 · AR · contact PI

Activation of B Cells by Host Toll-like Receptor Ligands$296,278

P01 · FY2008 · AR · contact PI

Administrative Core$53,692

P01 · FY2008 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,340,030

P01 · FY2007 · AR · contact PI

Research Program in Immunology$576,958

T32 · FY2007 · AI · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$333,404

P01 · FY2007 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$312,419

R01 · FY2007 · AR · contact PI

Administrative Core$58,402

P01 · FY2007 · AR · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,339,851

P01 · FY2006 · AR · contact PI

Activation of B Cells by Host Toll-Like Receptor Ligands$411,639

P01 · FY2006 · AR · contact PI

B Cell Hyperactivity in Autoimmunity$344,850

R01 · FY2006 · AR · contact PI

Research Program in Immunology$239,731

T32 · FY2006 · AI · contact PI

Toll-Like Receptors in Systemic Autoimmune Disease$1,332,138

P01 · FY2005 · AR

Research Program in Immunology$529,220

T32 · FY2005 · AI

Activation of B Cells by Host Toll-Like Receptor Ligands$399,654

P01 · FY2005 · AR

B CELL HYPERACTIVITY IN AUTOIMMUNITY$309,700

R01 · FY2005 · AR

Functions of Transmembrane and Soluble Fas ligand$270,580

R01 · FY2005 · CA

Toll-Like Receptors in Systemic Autoimmune Disease$1,312,256

P01 · FY2004 · AR

Research Program in Immunology$569,312

T32 · FY2004 · AI

Activation of B Cells by Host Toll-Like Receptor Ligands$388,010

P01 · FY2004 · AR

B CELL HYPERACTIVITY IN AUTOIMMUNITY$309,700

R01 · FY2004 · AR

Functions of Transmembrane and Soluble Fas ligand$270,580

R01 · FY2004 · CA

Research Program in Immunology$562,611

T32 · FY2003 · AI

TLR/BCR Synergy in an Autoreactive B Cell Activation$504,229

R01 · FY2003 · AR

B CELL HYPERACTIVITY IN AUTOIMMUNITY$309,700

R01 · FY2003 · AR

Functions of Transmembrane and Soluble Fas ligand$270,580

R01 · FY2003 · CA

Functions of Transmembrane and Soluble Fas ligand$440,287

R01 · FY2002 · CA

RESEARCH TRAINING IN IMMUNOLOGY$387,895

T32 · FY2002 · AI

B CELL HYPERACTIVITY IN AUTOIMMUNITY$309,700

R01 · FY2002 · AR

CORE--ANIMAL FACILITY$0

P01 · FY2002 · AI

RESEARCH TRAINING IN IMMUNOLOGY$352,952

T32 · FY2001 · AI

B CELL HYPERACTIVITY IN AUTOIMMUNITY$309,700

R01 · FY2001 · AR

Functions of Transmembrane and Soluble Fas ligand$270,580

R01 · FY2001 · CA

Functions of Transmembrane and Soluble Fas ligand$117,469

R01 · FY2001 · CA

RESEARCH TRAINING IN IMMUNOLOGY$336,765

T32 · FY2000 · AI

CORE--ANIMAL FACILITY$151,479

U19 · FY2000 · AI

B CELL HYPERACTIVITY IN AUTOIMMUNITY$100,000

R01 · FY2000 · AR

DISTINCT EFFECTS OF TRANSMEMBRANE AND SOLUBLE FAS LIGAND$87,663

R21 · FY2000 · GM